Immunointervention based on Th2-type cytokines in HIV infection.
Galanaud
P
P
Unité INSERM 131 et Service de Médecine Interne et Immunologie Clinique, Hôpital Antoine-Beclère, Institut Paris-Sud sur les Cytokines, Clamart, France.
Fior
R
R
Boue
F
F
Emilie
D
D
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D015870:Gene Expression; D015658:HIV Infections / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007378:Interleukins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D008251:Macaca; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy; D018418:Th2 Cells / Q000276:immunology*
D000911:Antibodies, Monoclonal; D016207:Cytokines; D007378:Interleukins